| Jan 31, 2022 | Jan 31, 2023 |
---|
Net loss, including amounts attributable to noncontrolling interest | -158 | -181 |
---|
Stock-based compensation expense | 30 | 123 |
---|
Operating Lease, Expense | - | 1 |
---|
Gain from the fair value change of acquisition related contingent consideration | - | -2 |
---|
Amortization of intangible assets | 1 | 2 |
---|
Depreciation expense | 1 | 3 |
---|
Capitalized Contract Cost, Amortization | 33 | 45 |
---|
Gain from deconsolidation of Meltano Inc. | - | 18 |
---|
Loss from equity method investment | - | -3 |
---|
Net amortization of premiums or discounts on short-term investments | - | 6 |
---|
Unrealized foreign exchange (gain) loss | -20 | 4 |
---|
Other non-cash expense, net | -0 | -1 |
---|
Accounts receivable | 38 | 54 |
---|
Prepaid expenses and other current assets | 8 | 9 |
---|
Deferred contract acquisition costs | 43 | 49 |
---|
Other long-term assets | 3 | -3 |
---|
Accounts payable | 2 | 0 |
---|
Accrued expenses and other current liabilities | 14 | 5 |
---|
Accrued compensation and benefits | 20 | -12 |
---|
Deferred revenue | 79 | 73 |
---|
Other long-term liabilities | 0 | -2 |
---|
Net cash used in operating activities | -50 | -77 |
---|
Purchases of short-term investments | - | 822 |
---|
Proceeds from maturities of short-term investments | - | 232 |
---|
Purchases of property and equipment | 4 | 6 |
---|
Deconsolidation of Meltano Inc. | - | 10 |
---|
Payments for business combination, net of cash acquired and consideration withheld in an escrow | 0 | - |
---|
Net cash used in investing activities | -54 | -606 |
---|
Proceeds from Issuance Initial Public Offering | 655 | - |
---|
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised | 25 | 25 |
---|
Proceeds from Stock Plans | - | 14 |
---|
Proceeds from Warrant Exercises | 0 | - |
---|
Repurchase of common stock in a tender offer | 1 | - |
---|
Proceeds from Noncontrolling Interests | 26 | 62 |
---|
Partial settlement of acquisition related contingent cash consideration | - | 3 |
---|
Payments of deferred offering costs | 5 | - |
---|
Net cash provided by financing activities | 701 | 97 |
---|
Impact of foreign exchange on cash and cash equivalents | 7 | -4 |
---|
Net increase (decrease) in cash and cash equivalents | 604 | -589 |
---|
Income Taxes Paid, Net | 1 | 1 |
---|
Cash donations | 1 | - |
---|
Stock Issued | 7 | 5 |
---|
Conversion of Stock, Amount Converted | 425 | - |
---|
Capital Expenditures Incurred but Not yet Paid | 0 | - |
---|